Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$42.05 - $47.77 $5.2 Million - $5.91 Million
-123,778 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$40.23 - $47.74 $597,817 - $709,416
14,860 Added 13.64%
123,778 $5.39 Million
Q4 2021

Feb 04, 2022

BUY
$38.88 - $45.31 $1.82 Million - $2.12 Million
46,866 Added 75.53%
108,918 $4.8 Million
Q3 2021

Nov 10, 2021

SELL
$38.79 - $43.16 $132,700 - $147,650
-3,421 Reduced 5.23%
62,052 $2.37 Million
Q2 2021

Aug 10, 2021

BUY
$36.52 - $41.46 $260,497 - $295,734
7,133 Added 12.23%
65,473 $2.61 Million
Q1 2021

Aug 10, 2021

BUY
$34.27 - $40.01 $14,770 - $17,244
431 Added 0.74%
58,340 $2.08 Million
Q1 2021

May 11, 2021

SELL
$34.27 - $40.01 $241,740 - $282,230
-7,054 Reduced 10.86%
57,909 $2.07 Million
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $540,384 - $633,488
-15,861 Reduced 19.62%
64,963 $2.39 Million
Q3 2020

Dec 10, 2020

BUY
$38.11 - $42.99 $62,004 - $69,944
1,627 Added 2.05%
80,824 $3.04 Million
Q2 2020

Aug 10, 2020

SELL
$37.87 - $43.58 $508,139 - $584,756
-13,418 Reduced 14.49%
79,197 $3.23 Million
Q1 2020

May 18, 2020

SELL
$32.47 - $48.83 $1.29 Million - $1.93 Million
-39,619 Reduced 29.96%
92,615 $3.51 Million
Q4 2019

Feb 13, 2020

SELL
$42.0 - $48.25 $261,786 - $300,742
-6,233 Reduced 4.5%
132,234 $6.21 Million
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $819,760 - $881,758
20,261 Added 17.14%
138,467 $5.91 Million
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $230,765 - $250,093
5,857 Added 5.21%
118,206 $4.73 Million
Q1 2019

Apr 23, 2019

BUY
$38.57 - $42.69 $292,862 - $324,145
7,593 Added 7.25%
112,349 $4.7 Million
Q1 2019

Apr 12, 2019

BUY
$38.57 - $42.69 $4.04 Million - $4.47 Million
104,756 New
104,756 $4 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.